Tuesday, July 09, 2013 11:46:16 AM
Each PR costs $$$.
IMHO, presently there are a couple of monumental events being ironed out. If folks would look closely, they will see that there have been successful human trials directly related to the therapy presently being considered by the FDA for approval.
For all we know, Koos could be negotiating with a BP for trials funding for this while at the same time dotting i's and crossing t's for the next FDA submission. We just don't know. Understanding that when a BP spots a treatment that they want to add to their collection, they will happily fund the trials for said treatment. That leaves $$$ for Koos to pursue more treatments/sciences to generate more $$$ thereby ultimately lining the pockets of shareholders.
But, we will very soon.
Go BMSN.
IMHO, presently there are a couple of monumental events being ironed out. If folks would look closely, they will see that there have been successful human trials directly related to the therapy presently being considered by the FDA for approval.
For all we know, Koos could be negotiating with a BP for trials funding for this while at the same time dotting i's and crossing t's for the next FDA submission. We just don't know. Understanding that when a BP spots a treatment that they want to add to their collection, they will happily fund the trials for said treatment. That leaves $$$ for Koos to pursue more treatments/sciences to generate more $$$ thereby ultimately lining the pockets of shareholders.
But, we will very soon.
Go BMSN.
Sometimes, you just have to walk away, let the dust settle and look at it all from a different perspective.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
